Literature DB >> 17177963

Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection.

L Meroni1, L Milazzo, B Menzaghi, R Mazzucchelli, D Mologni, P Morelli, V Broggini, F Adorni, M Galli, A Riva.   

Abstract

CD81 is a member of the tetraspan superfamily and plays a role in immune responses and in hepatitis C virus (HCV) pathogenesis. We analysed CD81 cell surface and mRNA expression in different lymphocytic subpopulations in human immunodeficiency virus (HIV)-1, HCV and dually infected subjects. CD81 cell surface expression was evaluated with fluorescence activated cell sorter (FACS) analysis; mRNA quantification was performed with semiquantitative polymerase chain reaction (PCR). CD81 cell surface expression on CD4(+) T lymphocytes was significantly different by analysis of variance (anova) test (P < 0.001), with reduced expression in HIV-1(+) patients. In B lymphocytes, higher cell surface expression was present in HIV-1, in HCV and in dually infected subjects compared to healthy controls. CD81 expression on B lymphocytes showed a positive correlation with plasma HIV-RNA. CD81 mRNA levels in B lymphocytes were significantly higher in HIV-1(+) patients compared to healthy controls. The potential consequence of the down-regulation of CD81 in CD4(+) cells during HIV-1 infection in conjunction with diverted CD28, CD4 and CD3 expression is the disruption of T cell function. Increased CD81 expression on B lymphocytes might explain the higher prevalence of lymphoproliferative disorders in HIV-1 and HCV infection. Up-regulation of CD81 mRNA on CD4(+) T cells indicates that down-regulation of CD81 occurs at the post-transcriptional/translational level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177963      PMCID: PMC1810438          DOI: 10.1111/j.1365-2249.2006.03250.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  53 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Anti-CD81 activates LFA-1 on T cells and promotes T cell-B cell collaboration.

Authors:  S E VanCompernolle; S Levy; S C Todd
Journal:  Eur J Immunol       Date:  2001-03       Impact factor: 5.532

3.  CD81 and CD28 costimulate T cells through distinct pathways.

Authors:  D A Witherden; R Boismenu; W L Havran
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

Review 4.  Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation.

Authors:  Eli Zuckerman
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

5.  Crosslinking CD81 results in activation of TCRgammadelta T cells.

Authors:  C T Tseng; E Miskovsky; G R Klimpel
Journal:  Cell Immunol       Date:  2001-01-10       Impact factor: 4.868

6.  Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

Authors:  A Wack; E Soldaini; C Tseng; S Nuti; G Klimpel; S Abrignani
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

7.  Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes.

Authors:  K E Willard-Gallo; M Furtado; A Burny; S M Wolinsky
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

8.  Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.

Authors:  J García-Samaniego; M Rodríguez; J Berenguer; R Rodríguez-Rosado; J Carbó; V Asensi; V Soriano
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

9.  Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.

Authors:  B Kronenberger; B Rüster; R Elez; S Weber; A Piiper; J H Lee; W K Roth; S Zeuzem
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

10.  HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

Authors:  S Moir; A Malaspina; K M Ogwaro; E T Donoghue; C W Hallahan; L A Ehler; S Liu; J Adelsberger; R Lapointe; P Hwu; M Baseler; J M Orenstein; T W Chun; J A Mican; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

View more
  3 in total

1.  Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Authors:  Petrus Jansen van Vuren; Caroline T Tiemessen; Janusz T Paweska
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

Review 2.  Tetraspanins, Another Piece in the HIV-1 Replication Puzzle.

Authors:  Henar Suárez; Vera Rocha-Perugini; Susana Álvarez; María Yáñez-Mó
Journal:  Front Immunol       Date:  2018-08-03       Impact factor: 7.561

3.  A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.

Authors:  Boyan Grigorov; Valérie Attuil-Audenis; Fabien Perugi; Martine Nedelec; Sarah Watson; Claudine Pique; Jean-Luc Darlix; Hélène Conjeaud; Delphine Muriaux
Journal:  Retrovirology       Date:  2009-03-11       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.